Logo image of ICL

ICL GROUP LTD (ICL) Stock Fundamental Analysis

NYSE:ICL - New York Stock Exchange, Inc. - IL0002810146 - Common Stock

5.91  +0.2 (+3.5%)

After market: 5.9299 +0.02 (+0.34%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ICL. ICL was compared to 85 industry peers in the Chemicals industry. While ICL belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. ICL has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ICL had positive earnings in the past year.
ICL had a positive operating cash flow in the past year.
Each year in the past 5 years ICL has been profitable.
Each year in the past 5 years ICL had a positive operating cash flow.
ICL Yearly Net Income VS EBIT VS OCF VS FCFICL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

1.2 Ratios

ICL has a better Return On Assets (3.50%) than 60.24% of its industry peers.
Looking at the Return On Equity, with a value of 6.88%, ICL is in line with its industry, outperforming 55.42% of the companies in the same industry.
The Return On Invested Capital of ICL (5.79%) is better than 65.06% of its industry peers.
ICL had an Average Return On Invested Capital over the past 3 years of 14.30%. This is significantly above the industry average of 6.59%.
The last Return On Invested Capital (5.79%) for ICL is well below the 3 year average (14.30%), which needs to be investigated, but indicates that ICL had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.5%
ROE 6.88%
ROIC 5.79%
ROA(3y)10.34%
ROA(5y)7.26%
ROE(3y)22.68%
ROE(5y)16.08%
ROIC(3y)14.3%
ROIC(5y)10.38%
ICL Yearly ROA, ROE, ROICICL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30

1.3 Margins

With a decent Profit Margin value of 5.83%, ICL is doing good in the industry, outperforming 66.27% of the companies in the same industry.
In the last couple of years the Profit Margin of ICL has declined.
The Operating Margin of ICL (11.21%) is better than 61.45% of its industry peers.
In the last couple of years the Operating Margin of ICL has grown nicely.
ICL's Gross Margin of 32.91% is fine compared to the rest of the industry. ICL outperforms 63.86% of its industry peers.
In the last couple of years the Gross Margin of ICL has remained more or less at the same level.
Industry RankSector Rank
OM 11.21%
PM (TTM) 5.83%
GM 32.91%
OM growth 3Y37.77%
OM growth 5Y2.93%
PM growth 3Y240.16%
PM growth 5Y-17.39%
GM growth 3Y6.25%
GM growth 5Y1.21%
ICL Yearly Profit, Operating, Gross MarginsICL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40 50

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ICL is creating value.
Compared to 1 year ago, ICL has about the same amount of shares outstanding.
Compared to 5 years ago, ICL has more shares outstanding
The debt/assets ratio for ICL has been reduced compared to a year ago.
ICL Yearly Shares OutstandingICL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B
ICL Yearly Total Debt VS Total AssetsICL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B 10B

2.2 Solvency

ICL has an Altman-Z score of 2.48. This is not the best score and indicates that ICL is in the grey zone with still only limited risk for bankruptcy at the moment.
ICL has a Altman-Z score of 2.48. This is in the better half of the industry: ICL outperforms 68.67% of its industry peers.
ICL has a debt to FCF ratio of 3.36. This is a good value and a sign of high solvency as ICL would need 3.36 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.36, ICL belongs to the top of the industry, outperforming 83.13% of the companies in the same industry.
ICL has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
ICL has a Debt to Equity ratio of 0.31. This is in the better half of the industry: ICL outperforms 71.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.36
Altman-Z 2.48
ROIC/WACC0.76
WACC7.63%
ICL Yearly LT Debt VS Equity VS FCFICL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B 4B 5B

2.3 Liquidity

ICL has a Current Ratio of 1.56. This is a normal value and indicates that ICL is financially healthy and should not expect problems in meeting its short term obligations.
ICL's Current ratio of 1.56 is on the low side compared to the rest of the industry. ICL is outperformed by 66.27% of its industry peers.
ICL has a Quick Ratio of 1.56. This is a bad value and indicates that ICL is not financially healthy enough and could expect problems in meeting its short term obligations.
ICL has a worse Quick ratio (0.91) than 72.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 0.91
ICL Yearly Current Assets VS Current LiabilitesICL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B

2

3. Growth

3.1 Past

The earnings per share for ICL have decreased strongly by -46.67% in the last year.
The Earnings Per Share has been growing by 9.03% on average over the past years. This is quite good.
ICL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.11%.
ICL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.29% yearly.
EPS 1Y (TTM)-46.67%
EPS 3Y39.49%
EPS 5Y9.03%
EPS Q2Q%0%
Revenue 1Y (TTM)-12.11%
Revenue growth 3Y14.33%
Revenue growth 5Y6.29%
Sales Q2Q%-5.85%

3.2 Future

Based on estimates for the next years, ICL will show a decrease in Earnings Per Share. The EPS will decrease by -5.69% on average per year.
Based on estimates for the next years, ICL will show a small growth in Revenue. The Revenue will grow by 0.38% on average per year.
EPS Next Y-33.11%
EPS Next 2Y-14.84%
EPS Next 3Y-5.69%
EPS Next 5YN/A
Revenue Next Year-6.77%
Revenue Next 2Y-1.76%
Revenue Next 3Y0.38%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ICL Yearly Revenue VS EstimatesICL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B 8B 10B
ICL Yearly EPS VS EstimatesICL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 14.78, the valuation of ICL can be described as correct.
ICL's Price/Earnings ratio is a bit cheaper when compared to the industry. ICL is cheaper than 77.11% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.96. ICL is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 14.30 indicates a correct valuation of ICL.
Based on the Price/Forward Earnings ratio, ICL is valued a bit cheaper than 62.65% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.11, ICL is valued a bit cheaper.
Industry RankSector Rank
PE 14.78
Fwd PE 14.3
ICL Price Earnings VS Forward Price EarningsICL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

86.75% of the companies in the same industry are more expensive than ICL, based on the Enterprise Value to EBITDA ratio.
ICL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ICL is cheaper than 84.34% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.45
EV/EBITDA 6.95
ICL Per share dataICL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The decent profitability rating of ICL may justify a higher PE ratio.
ICL's earnings are expected to decrease with -5.69% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)1.64
EPS Next 2Y-14.84%
EPS Next 3Y-5.69%

5

5. Dividend

5.1 Amount

ICL has a Yearly Dividend Yield of 3.41%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.34, ICL pays a better dividend. On top of this ICL pays more dividend than 80.72% of the companies listed in the same industry.
ICL's Dividend Yield is a higher than the S&P500 average which is at 2.29.
Industry RankSector Rank
Dividend Yield 3.41%

5.2 History

On average, the dividend of ICL grows each year by 14.30%, which is quite nice.
ICL has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)14.3%
Div Incr Years0
Div Non Decr Years0
ICL Yearly Dividends per shareICL Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3

5.3 Sustainability

ICL pays out 62.13% of its income as dividend. This is not a sustainable payout ratio.
ICL's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP62.13%
EPS Next 2Y-14.84%
EPS Next 3Y-5.69%
ICL Yearly Income VS Free CF VS DividendICL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B 2B
ICL Dividend Payout.ICL Dividend Payout, showing the Payout Ratio.ICL Dividend Payout.PayoutRetained Earnings

ICL GROUP LTD

NYSE:ICL (1/17/2025, 8:07:20 PM)

After market: 5.9299 +0.02 (+0.34%)

5.91

+0.2 (+3.5%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-11 2024-11-11/bmo
Earnings (Next)02-05 2025-02-05/amc
Inst Owners26.04%
Inst Owner Change-0.74%
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap7.63B
Analysts48
Price Target0.05 (-99.15%)
Short Float %0.22%
Short Ratio1.85
Dividend
Industry RankSector Rank
Dividend Yield 3.41%
Yearly Dividend0.37
Dividend Growth(5Y)14.3%
DP62.13%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.06%
Min EPS beat(2)16.94%
Max EPS beat(2)25.18%
EPS beat(4)4
Avg EPS beat(4)22.64%
Min EPS beat(4)3.92%
Max EPS beat(4)44.54%
EPS beat(8)5
Avg EPS beat(8)10.36%
EPS beat(12)9
Avg EPS beat(12)25.24%
EPS beat(16)13
Avg EPS beat(16)24.05%
Revenue beat(2)0
Avg Revenue beat(2)-1.41%
Min Revenue beat(2)-1.41%
Max Revenue beat(2)-1.41%
Revenue beat(4)1
Avg Revenue beat(4)-1.77%
Min Revenue beat(4)-5.35%
Max Revenue beat(4)1.08%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.21%
PT rev (3m)5.48%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-16.49%
EPS NY rev (1m)0%
EPS NY rev (3m)3.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-13.7%
Revenue NY rev (1m)-0.38%
Revenue NY rev (3m)-1.59%
Valuation
Industry RankSector Rank
PE 14.78
Fwd PE 14.3
P/S 1.1
P/FCF 10.45
P/OCF 5.33
P/B 1.3
P/tB 1.54
EV/EBITDA 6.95
EPS(TTM)0.4
EY6.77%
EPS(NY)0.41
Fwd EY6.99%
FCF(TTM)0.57
FCFY9.57%
OCF(TTM)1.11
OCFY18.77%
SpS5.37
BVpS4.55
TBVpS3.84
PEG (NY)N/A
PEG (5Y)1.64
Profitability
Industry RankSector Rank
ROA 3.5%
ROE 6.88%
ROCE 8.53%
ROIC 5.79%
ROICexc 6.13%
ROICexgc 6.86%
OM 11.21%
PM (TTM) 5.83%
GM 32.91%
FCFM 10.53%
ROA(3y)10.34%
ROA(5y)7.26%
ROE(3y)22.68%
ROE(5y)16.08%
ROIC(3y)14.3%
ROIC(5y)10.38%
ROICexc(3y)15.18%
ROICexc(5y)10.96%
ROICexgc(3y)16.84%
ROICexgc(5y)12.14%
ROCE(3y)21.8%
ROCE(5y)15.86%
ROICexcg growth 3Y50.41%
ROICexcg growth 5Y5.23%
ROICexc growth 3Y49.81%
ROICexc growth 5Y5.09%
OM growth 3Y37.77%
OM growth 5Y2.93%
PM growth 3Y240.16%
PM growth 5Y-17.39%
GM growth 3Y6.25%
GM growth 5Y1.21%
F-Score4
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.36
Debt/EBITDA 1.35
Cap/Depr 119.83%
Cap/Sales 10.12%
Interest Coverage 6.7
Cash Conversion 105.07%
Profit Quality 180.69%
Current Ratio 1.56
Quick Ratio 0.91
Altman-Z 2.48
F-Score4
WACC7.63%
ROIC/WACC0.76
Cap/Depr(3y)140.07%
Cap/Depr(5y)135.65%
Cap/Sales(3y)8.86%
Cap/Sales(5y)9.99%
Profit Quality(3y)81.05%
Profit Quality(5y)389.78%
High Growth Momentum
Growth
EPS 1Y (TTM)-46.67%
EPS 3Y39.49%
EPS 5Y9.03%
EPS Q2Q%0%
EPS Next Y-33.11%
EPS Next 2Y-14.84%
EPS Next 3Y-5.69%
EPS Next 5YN/A
Revenue 1Y (TTM)-12.11%
Revenue growth 3Y14.33%
Revenue growth 5Y6.29%
Sales Q2Q%-5.85%
Revenue Next Year-6.77%
Revenue Next 2Y-1.76%
Revenue Next 3Y0.38%
Revenue Next 5YN/A
EBIT growth 1Y-49.28%
EBIT growth 3Y57.51%
EBIT growth 5Y9.4%
EBIT Next Year25.59%
EBIT Next 3Y11.24%
EBIT Next 5YN/A
FCF growth 1Y-38.24%
FCF growth 3Y66.05%
FCF growth 5Y72.73%
OCF growth 1Y-24.76%
OCF growth 3Y25.65%
OCF growth 5Y20.61%